Nisa Investment Advisors’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$217K Sell
6,253
-540
-8% -$14.5K ﹤0.01% 1218
2026
Q1
$141K Sell
6,793
-8,700
-56% -$206K ﹤0.01% 1319
2025
Q4
$503K Sell
15,493
-9,183
-37% -$393K ﹤0.01% 997
2025
Q3
$1.4M Buy
24,676
+5,852
+31% +$300K 0.01% 742
2025
Q2
$938K Buy
18,824
+14,106
+299% +$638K ﹤0.01% 827
2025
Q1
$139K Buy
4,718
+158
+3% +$5.87K ﹤0.01% 1313
2024
Q4
$110K Buy
4,560
+2,442
+115% +$60.5K ﹤0.01% 1449
2024
Q3
$39K Buy
2,118
+279
+15% +$5K ﹤0.01% 1703
2024
Q2
$37.1K Buy
1,839
+1,603
+679% +$26.7K ﹤0.01% 1746
2024
Q1
$3.65K Buy
236
+126
+115% +$1.42K ﹤0.01% 2153
2023
Q4
$979 Hold
110
﹤0.01% 2266
2023
Q3
$692 Hold
110
﹤0.01% 2465
2023
Q2
$1.03K Sell
110
-1,690
-94% -$16.8K ﹤0.01% 2430
2023
Q1
$18K Buy
1,800
+1,690
+1,536% +$14.8K ﹤0.01% 2035
2022
Q4
$1K Hold
110
﹤0.01% 2436
2022
Q3
$0 Buy
+110
New +$663 ﹤0.01% 2608

Other funds holding HIMS

Nisa Investment Advisors's HIMS Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Hims & Hers Health (HIMS) stake by 7.9% in Q2 2026, selling an estimated $14.5K and leaving 6,253 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #1218.

Nisa Investment Advisors first reported a position in HIMS in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.4M in Q3 2025. 242 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Nisa Investment Advisors held 6,253 shares of Hims & Hers Health worth $217K as of Q2 2026.
  • Nisa Investment Advisors sold 540 Hims & Hers Health shares in Q2 2026, an estimated $14.5K.
  • Hims & Hers Health made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1218 holding.
  • Nisa Investment Advisors first reported a position in Hims & Hers Health in Q3 2022 and has held it in 16 quarters since.
  • Nisa Investment Advisors's Hims & Hers Health position peaked at $1.4M in Q3 2025.
  • 242 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.